G Geisslinger

Programming of a flexible computer simulation to visualize pharmacokinetic-pharmacodynamic models.

G Kobal, J Lötsch, G Geisslinger, 2004, International journal of clinical pharmacology and therapeutics.

Molecular cloning and expression of a 2-arylpropionyl-coenzyme A epimerase: a key enzyme in the inversion metabolism of ibuprofen.

G Geisslinger, C. Reichel, H. Bang, 1997, Molecular pharmacology.

Effects of selective and unselective cyclooxygenase inhibitors on prostanoid release from various rat organs.

G Geisslinger, W. Neupert, G. Geisslinger, 2000, The Journal of pharmacology and experimental therapeutics.

Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signals.

G Geisslinger, E. Hahn, R. Oelkers, 1999, British journal of clinical pharmacology.

Computerized survelliance of adverse drug reactions in hospital: pilot study.

G Geisslinger, G. Geisslinger, K. Brune, 1998, British journal of clinical pharmacology.

Differential Opioid Action on Sensory and Affective Cerebral Pain Processing

J Lötsch, G Geisslinger, H. Lanfermann, 2008, Clinical pharmacology and therapeutics.

Pharmacokinetic-pharmacodynamic relationships for analgesics.

G Geisslinger, H Derendorf, H. Derendorf, 1997, International journal of clinical pharmacology and therapeutics.

Stereoselective high-performance liquid chromatographic determination of the enantiomers of ketamine and norketamine in plasma.

G Geisslinger, G. Geisslinger, K. Brune, 1991, Journal of chromatography.

Dysregulation of lysophosphatidic acids in multiple sclerosis and autoimmune encephalomyelitis

S Schiffmann, J Lötsch, G Geisslinger, 2017, Acta Neuropathologica Communications.